Azzad Asset Management Inc /Adv Ionis Pharmaceuticals Inc Transaction History

Azzad Asset Management Inc /Adv

  • $891 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Apr 01, 2024
SELL
$43.37 - $59.54 $366,519 - $503,172
-8,451 Closed
0 $0
Q2 2018

Apr 01, 2024
BUY
$40.53 - $50.7 $342,519 - $428,465
8,451 New
8,451 $352 Million
Q1 2018

Apr 03, 2024
BUY
$44.08 - $55.05 $17,632 - $22,020
400 Added 5.41%
7,787 $343 Million
Q2 2017

Apr 03, 2024
BUY
N/A
7,387
7,387 $376 Million

Others Institutions Holding IONS

# of Institutions
404
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email